Daewoong Hosts Nabota Academy for Partners From 22 Countries
Daewoong Pharmaceutical held a three-day program in Jeju for 40 partner-company personnel to strengthen their knowledge of Nabota and their academic and marketing capabilities.
This article was automatically drafted and passed editorial compliance checks. It synthesizes public source metadata and is not a substitute for individual care or clinical review.
Daewoong Pharmaceutical held the NABOTA EDGE Global Academic Program at the Parnas Hotel Jeju from September 3 to 5, 2026. The company brought together 40 key personnel from partner companies in 22 countries as it expands the international business for its botulinum toxin product Nabota.
Building partner capabilities
Daewoong Pharmaceutical designed the program to deepen partner companies’ understanding of the Nabota product and brand while strengthening their academic and marketing execution capabilities in their respective markets.
Daewoong Pharmaceutical has obtained marketing authorization for Nabota in 69 countries across regions including the United States, Europe and Asia, and has formed partnerships covering about 80 countries. The company’s cumulative sales of Nabota have passed KRW 1 trillion.
What the event means for readers
The event was a partner education and business-capability program rather than a clinical study of botulinum toxin treatment. Its concrete development was Daewoong Pharmaceutical’s effort to align product knowledge and local execution across its international partner network.
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
